AHA Scientific Sessions 2025 Abstract

Semaglutide Modulates the Cardio-Hepatic Axis By Mitigating Lipid and Fibrosis Deposition Independent of Weight Loss in Obese HFpEF

Experiments in animalsInterventions

The paper

Johns Hopkins University; Cedars-Sinai Medical Center

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4365079

doi.org/10.1161/circ.152.suppl_3.4365079